SQZ Biotechnologies Co

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$45.7M

142 transactions

Summary

SQZ Biotechnologies Co is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $45.5MSales: $4K34 insiders

Date	Insider	Type	Value
2022-06-30	Sharei Armon(President and CEO)	A	$7K
2022-06-30	Knopf Lawrence J(General Counsel)	A	$4K
2022-08-15	Capasso Richard(See Remarks)	Sell	$4K
2022-06-30	Capasso Richard(See Remarks)	A	$3K
2023-06-14	BOLNO PAUL	A	$0
2023-06-14	Coulie Bernard	A	$0
2023-06-14	Elia Marc	A	$0
2023-06-14	Garg Pushkal	A	$0
2023-06-14	Jensen Klavs F.	A	$0
2023-06-14	SCHEGERIN MARC	A	$0
2023-06-14	SCHULMAN AMY W	A	$0
2023-06-14	Srivastava Sapna	A	$0
2023-06-14	VINK PATRICK V.J.J.	A	$0
2023-01-24	BERNSTEIN HOWARD PHD MD(Interim Chief Executive Office)	A	$0
2023-01-24	First David(Chief People Officer)	A	$0
2023-01-24	Knopf Lawrence J(General Counsel)	A	$0
2023-01-24	Warren Marshelle Smith(Chief Medical Officer)	A	$0
2023-01-24	Capasso Richard(See Remarks)	A	$0
2022-07-11	Zajic Micah(Chief Financial Officer)	A	$0
2022-06-15	Coulie Bernard	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SQZ Biotechnologies Co — Contributions, Lobbying & Contracts | Poliscope